Close
Nordic 9Nordic 9

China Grand Pharmaceutical and Healthcare Holdings (investor - Others)

China
See something wrong or missing? Let us know
Offices:Beijing
Average round investment:31.06M USD
Average number per year:1.5
Distribution: 2022 (2)2020 (1)
Portfolio companies: Belgium eTheRNANetherlands Xeltis
Mostly invests in: Belgium Belgium (2) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to China Grand Pharmaceutical and Healthcare Holdings

Name Criteria
Netherlands Thuja Capital Management B.V.
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Wellington Partners
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Germany 2invest
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Alef 6
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Ace Ventures
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Taiwania Capital
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Fonds de solidarité FTQ
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Novateur Ventures
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway RadForsk
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.1
  • Active last 12 months: Yes
Belgium Capricorn Venture Partners
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top